Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$1 Mln
P/E Ratio
--
P/B Ratio
0.07
Industry P/E
81.98
Debt to Equity
0
ROE
-1.03 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-4.93
CFO
$-86.36 Mln
EBITDA
$-110.49 Mln
Net Profit
$-117.42 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Applied DNA Sciences (APDN)
| -91.50 | -51.59 | -90.21 | -94.75 | -78.80 | -69.30 | -58.18 |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Applied DNA Sciences (APDN)
| -66.80 | -62.65 | -58.71 | -21.18 | 21.72 | -73.81 | -74.65 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.65 | 10,289.47 | 14.38 | 12.69 | |
| 72.28 | 9,544.04 | 92.52 | 2.52 | |
| 158.95 | 8,064.21 | -- | -25.23 | |
| 278.44 | 10,728.90 | 773.26 | 1.2 |
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA... Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York. Address: 50 Health Sciences Drive, Stony Brook, NY, United States, 11790 Read more
Chairman, President & CEO
Dr. James A. Hayward Ph.D., Sc.D.
Chairman, President & CEO
Dr. James A. Hayward Ph.D., Sc.D.
Headquarters
Stony Brook, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Applied DNA Sciences Inc (APDN) stood at $ 18 Mln as on 31-Dec-24
The share price of Applied DNA Sciences Inc (APDN) is $0.87 (NASDAQ) as of 23-Apr-2025 14:40 EDT. Applied DNA Sciences Inc (APDN) has given a return of -78.8% in the last 3 years.
Applied DNA Sciences Inc (APDN) has a market capitalisation of $ 1 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Applied DNA Sciences Inc (APDN) is 0.07 times as on 22-Apr-2025, a 98% discount to its peers’ median range of 3.26 times.
Since, TTM earnings of Applied DNA Sciences Inc (APDN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Applied DNA Sciences Inc (APDN) and enter the required number of quantities and click on buy to purchase the shares of Applied DNA Sciences Inc (APDN).
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York. Address: 50 Health Sciences Drive, Stony Brook, NY, United States, 11790
The CEO & director of Dr. James A. Hayward Ph.D., Sc.D.. is Applied DNA Sciences Inc (APDN), and CFO & Sr. VP is Dr. James A. Hayward Ph.D., Sc.D..
There is no promoter pledging in Applied DNA Sciences Inc (APDN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Applied DNA Sciences Inc. (APDN) | Ratios |
|---|---|
|
Return on equity(%)
|
-67.03
|
|
Operating margin(%)
|
-273.91
|
|
Net Margin(%)
|
-228.18
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Applied DNA Sciences Inc (APDN) was $0 Mln.
$-0.03
(
